Matches in Wikidata for { <http://www.wikidata.org/entity/Q80368504> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q80368504 description "article scientifique (publié 2007)" @default.
- Q80368504 description "artikull shkencor i botuar më 01 janar 2007" @default.
- Q80368504 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q80368504 description "im Jahr 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80368504 description "scientific article published on 01 January 2007" @default.
- Q80368504 description "wetenschappelijk artikel" @default.
- Q80368504 description "наукова стаття, опублікована в січні 2007" @default.
- Q80368504 description "գիտական հոդված հրատարակված 2007 թվականի հունվարի 1-ին" @default.
- Q80368504 name "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 name "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 name "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 type Item @default.
- Q80368504 label "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 label "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 label "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 prefLabel "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 prefLabel "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 prefLabel "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 P1433 Q80368504-FFAC0ADF-BAB4-4B51-84FE-32788549A7CB @default.
- Q80368504 P1476 Q80368504-27BA5E36-CF54-4DCA-8CF6-29E193CB4AD8 @default.
- Q80368504 P2093 Q80368504-38EEBB1D-DBA0-4658-9D7D-6A5F8969B224 @default.
- Q80368504 P2093 Q80368504-7065E0EC-D68D-4589-9CC3-248953BB84D3 @default.
- Q80368504 P2093 Q80368504-82066093-352A-4A86-ACFD-C69A6EBF0CC2 @default.
- Q80368504 P2093 Q80368504-82EA7354-AE20-431B-BC4D-AE0481FC9496 @default.
- Q80368504 P2093 Q80368504-B95059D7-A7BB-4B7D-9200-19200736FF98 @default.
- Q80368504 P2093 Q80368504-BA8F7517-9D31-4AB1-BFC2-5302BC87CBBB @default.
- Q80368504 P2093 Q80368504-BC571DFC-9AEE-4809-8912-82765BF83631 @default.
- Q80368504 P2093 Q80368504-C77812B3-DCC6-496E-9435-ACB8F371FA89 @default.
- Q80368504 P2093 Q80368504-D8910C53-CDE7-4CE8-87D0-253E5B2FF02C @default.
- Q80368504 P2093 Q80368504-FDB28060-282F-4832-8ED3-CDAA4A32699A @default.
- Q80368504 P304 Q80368504-6685A9BC-FADB-4DC6-BA55-69CE9E7F3BA8 @default.
- Q80368504 P31 Q80368504-A5EB883D-38FD-4AC4-B8F8-E5D51A51026C @default.
- Q80368504 P356 Q80368504-B84587B7-5138-4E19-8CF7-4EB43DBDC89D @default.
- Q80368504 P433 Q80368504-F381A429-501B-4D4A-83E2-85FA92F5E2C1 @default.
- Q80368504 P478 Q80368504-0175404D-A899-438E-B339-3E1DA6F6AFD8 @default.
- Q80368504 P577 Q80368504-72E05EC2-F489-4153-BDE7-F1C0205BDAED @default.
- Q80368504 P698 Q80368504-1D999DAD-318B-4B58-8C39-53084D5D3C73 @default.
- Q80368504 P921 Q80368504-03834787-2D18-46A1-9B9C-1C50AB866FE2 @default.
- Q80368504 P356 000000006783980955 @default.
- Q80368504 P698 17518272 @default.
- Q80368504 P1433 Q15750114 @default.
- Q80368504 P1476 "Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: an analysis of prognostic factors in the treatment" @default.
- Q80368504 P2093 "Akira Yamada" @default.
- Q80368504 P2093 "Junko Mizoguchi" @default.
- Q80368504 P2093 "Kazumi Yoshida" @default.
- Q80368504 P2093 "Kei Matsuoka" @default.
- Q80368504 P2093 "Kyogo Itoh" @default.
- Q80368504 P2093 "Mamoru Harada" @default.
- Q80368504 P2093 "Masanori Noguchi" @default.
- Q80368504 P2093 "Shigetaka Suekane" @default.
- Q80368504 P2093 "Takashi Mine" @default.
- Q80368504 P2093 "Yayoi Obata" @default.
- Q80368504 P304 "341-349" @default.
- Q80368504 P31 Q13442814 @default.
- Q80368504 P356 "10.3727/000000006783980955" @default.
- Q80368504 P433 "7" @default.
- Q80368504 P478 "16" @default.
- Q80368504 P577 "2007-01-01T00:00:00Z" @default.
- Q80368504 P698 "17518272" @default.
- Q80368504 P921 Q181257 @default.